Efficacy and Safety of Sublingual Tablets of Grass Pollen Allergen Extract (Q64722999)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and Safety of Sublingual Tablets of Grass Pollen Allergen Extract |
clinical trial |
Statements
A Randomised, Double-blind, in Parallel Groups Placebo-controlled, Mono-centre, Phase I Study to Assess After Allergen Challenge in an Allergen Exposition Chamber the Effect and Its Time Course of Sublingual Immunotherapy (SLIT) Administered as 300IR Allergen-based Tablets Once Daily to Adults Suffering From Grass Pollen Rhinoconjunctivitis (English)
0 references
September 2007
0 references
March 2008
0 references
89
0 references
18 year
0 references
50 year
0 references